Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania

• Published in: PloS one Vol. 9; no. 3; p. e91229
• Main Authors: Nagu, Tumaini J, Spiegelman, Donna, Hertzmark, Ellen, Aboud, Said, Makani, Julie, Matee, Mecky I, Fawzi, Wafaie, Mugusi, Ferdinand
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 18.03.2014; Public Library of Science (PLoS)
• Subjects: Adolescent; Adult; Anemia; Anemia - complications; Anemia - diagnosis; Anemia - drug therapy; Anemia - microbiology; Antitubercular Agents - therapeutic use; Bacilli; Bacterial infections; Biochemistry; Biology and Life Sciences; Blood tests; Care and treatment; Chemotherapy; Clinical outcomes; Conversion; Drugs; Epidemiology; Female; Females; Hemoglobin; Hemoglobins; Humans; Immunology; Internal medicine; Iron; Male; Males; Medicin och hälsovetenskap; Medicine and Health Sciences; Microscopy; Middle Aged; Mortality; Mycobacterium tuberculosis - drug effects; Mycobacterium tuberculosis - physiology; Patients; Prospective Studies; Public health; Pulmonary tuberculosis; Research and Analysis Methods; Risk; Severity of Illness Index; Smear; Sputum; Sputum - microbiology; Systematic review; Tanzania; Therapy; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary - complications; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - drug therapy; Tuberculosis, Pulmonary - microbiology; Tanzania; United States > US; Massachusetts
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0091229

Pulmonary tuberculosis and anemia are both prevalent in Tanzania. There is limited and inconsistent literature on the association between anemia and sputum conversion following tuberculosis treatment. Newly diagnosed sputum smear positive pulmonary tuberculosis patients aged ≥15 years initiating on standard anti tuberculosis therapy were recruited from 14 of 54 tuberculosis clinics in Dar es Salaam. Patients were receiving medication according to the recommended short course Directly Observed Therapy (DOT) strategy and were followed up prospectively until completion of treatment (six months). Patients were evaluated before initiation of TB treatment by performing the following; clinical history, physical examination, complete blood counts, serum biochemistry and sputum microscopy. Sputum smears were re-examined at two months of anti-tuberculosis therapy for presence of acid fast bacilli. Anemia was defined as hemoglobin <13 g/dl (males) or <12 g/dl (females). Log-binomial regression was used to assess the association between anemia and sputum conversion at two months. Of the 1245 patients included in the study, 86% were anemic and 7% were sputum smear positive at two months of anti-tuberculosis therapy. Anemic patients were three times more likely to have sputum positive smear as compared to non-anemic patients at two months (RR = 3.05; 95% CI 1.11-8.40) p = 0.03. The risk for sputum positive smear results increased with severity of anemia (P for trend <0.01). Baseline anemia is associated with increased risk for persistent positive sputum smears at two months of tuberculosis treatment. Future studies should evaluate the mechanisms for TB-associated anemia as well as the role of intervention for anemia among TB patients.